Connect your AI

Markel MKL Industrial — Sale of Global Reinsurance renewal rights

Similar metrics at other companies

MOG.BIndustrial — Reclassification of held for sale

$0—

TAYDIndustrial — Revenue

$1.08M+23.7%

OIndustrial — Rental (including reimbursements)

$234.53M+12.7%

VREXIndustrial — Revenues, net

$59.8M+1.2%

DCOIndustrial — Net Revenues

$7.48M-16.0%

RBCIndustrial — Revenue

$295.9M+5.5%

Other financials

Income statement

Revenue$3.6B+0.1%

Operating income-$273.3M-197%

Net income-$212.3M-274%

EPS (diluted)-$18.90-256%

Balance sheet

Cash & equivalents$3.7B-12.2%

Total debt$4.4B-0.2%

Total equity$18.1B+5.7%

Total assets$68.6B+6.2%

Cash flow

Operating cash flow$15.9M-95.8%

CapEx$47.3M+16.1%

Free cash flow-$31.4M-109%

Valuation

Market cap$24.44B-2.1%

Enterprise value$25.14B-1.8%

P/E13.8×+2.6×

P/S1.5×-0.1×

Profitability

Operating margin16.4%-1.7pp

Net margin11%-1.6pp

FCF margin13.6%-0.8pp

Returns & leverage

Return on equity10.1%-1.2pp

Debt / equity0.2×0.0×

Where this comes from

Reported directly by Markel in its filing.

Tagged under the XBRL concept mkl:SaleOfGlobalReinsuranceRenewalRights.

The official record: Markel’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Markel's industrial — sale of global reinsurance renewal rights.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Markel's industrial — sale of global reinsurance renewal rights?: Markel (MKL) reported industrial — sale of global reinsurance renewal rights of $0 in Q4 2025.
What does industrial — sale of global reinsurance renewal rights mean?: This metric represents the proceeds or financial impact resulting from the divestiture of rights to renew specific reinsurance contracts within the industrial or non-insurance business segment. It reflects a strategic decision to exit or transfer a portion of the insurance-related portfolio to focus on core industrial operations. Such transactions are typically non-recurring and indicate a shift in the company's capital allocation strategy.